CIK 0001682852
- Large accelerated filer
Moderna, Inc.
Sign in to watch- Ticker
- MRNA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813467528
- Phone
- +1 617-714-6500
- Business address
- 325 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- Moderna Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $50,775,837
- in 5 filings, $50.8M under 10b5-1 plans
Net −$50,775,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-04-03 | AFEYAN NOUBAR Director | Sale 10b5-1 | −200 | $97.47 | $19K | 2,101,731 |
| 2024-04-03 | AFEYAN NOUBAR Director | Sale 10b5-1 | −1,499 | $99.40 | $149K | 2,100,232 |
| 2024-04-03 | AFEYAN NOUBAR Director | Sale 10b5-1 | −3,167 | $100.66 | $319K | 2,097,065 |
| 2024-04-03 | AFEYAN NOUBAR Director | Sale 10b5-1 | −3,832 | $101.33 | $388K | 2,093,233 |
| 2024-04-03 | AFEYAN NOUBAR Director | Sale 10b5-1 | −3,500 | $102.64 | $359K | 2,089,733 |
| 2024-04-03 | AFEYAN NOUBAR Director | Sale 10b5-1 | −2,702 | $103.64 | $280K | 2,087,031 |
| 2024-04-03 | AFEYAN NOUBAR Director | Sale 10b5-1 | −100 | $104.15 | $10K | 2,086,931 |
| 2024-03-27 | AFEYAN NOUBAR Director | Sale 10b5-1 | −1,817 | $105.73 | $192K | 2,115,114 |
| 2024-03-27 | AFEYAN NOUBAR Director | Sale 10b5-1 | −1,100 | $106.71 | $117K | 2,114,014 |
| 2024-03-27 | AFEYAN NOUBAR Director | Sale 10b5-1 | −1,466 | $107.79 | $158K | 2,112,548 |
| 2024-03-27 | AFEYAN NOUBAR Director | Sale 10b5-1 | −3,100 | $109.09 | $338K | 2,109,448 |
| 2024-03-27 | AFEYAN NOUBAR Director | Sale 10b5-1 | −4,544 | $110.24 | $501K | 2,104,904 |
| 2024-03-27 | AFEYAN NOUBAR Director | Sale 10b5-1 | −2,973 | $110.75 | $329K | 2,101,931 |
| 2024-03-20 | AFEYAN NOUBAR Director | Sale 10b5-1 | −2,113 | $101.05 | $214K | 2,129,818 |
| 2024-03-20 | AFEYAN NOUBAR Director | Sale 10b5-1 | −7,109 | $102.15 | $726K | 2,122,709 |
| 2024-03-20 | AFEYAN NOUBAR Director | Sale 10b5-1 | −5,778 | $103.18 | $596K | 2,116,931 |
| 2024-03-15 | Hoge Stephen President | Sale 10b5-1 | −15,000 | $103.17 | $1.5M | 1,501,241 |
| 2024-03-13 | AFEYAN NOUBAR Director | Sale 10b5-1 | −6,281 | $106.60 | $670K | 2,140,650 |
| 2024-03-13 | AFEYAN NOUBAR Director | Sale 10b5-1 | −2,300 | $107.66 | $248K | 2,138,350 |
| 2024-03-13 | AFEYAN NOUBAR Director | Sale 10b5-1 | −600 | $108.52 | $65K | 2,137,750 |
Page 33 of 38 · 743 trades